Autonomic modulation of heart rate of young and postmenopausal women undergoing estrogen therapy

The aim of the present study was to determine whether estrogen therapy (ET) reduces alterations of the autonomic control of heart rate (HR) due to hypoestrogenism and aging. Thirteen young (24 ± 2.6 years), 10 postmenopausal (53 ± 4.6 years) undergoing ET (PM-ET), and 14 postmenopausal (56 ± 2.6 years) women not undergoing ET (PM) were studied. ET consisted of 0.625 mg/day conjugated equine estrogen. HR was recorded continuously for 8 min at rest in the supine and sitting positions. HR variability (HRV) was analyzed by time (SDNN and rMSSD indices) and frequency domain methods. Power spectral components are reported as normalized units (nu) at low (LF) and high (HF) frequencies, and as LF/HF ratio. Intergroup comparisons: SDNN index was higher in young (median: supine, 47 ms; sitting, 42 ms) than in PM-ET (33; 29 ms) and PM (31; 29 ms) women (P < 0.05). PM showed lower HFnu, higher LFnu and higher LF/HF ratio (supine: 44, 56, 1.29; sitting: 38, 62, 1.60) than the young group in the supine position (61, 39, 0.63) and the PM-ET group in the sitting position (57, 43, 0.75; P < 0.05). Intragroup comparisons: HR was lower in the supine than in the sitting position for all groups (P < 0.05). The HRV decrease from the supine to the sitting position was significant only in the young group. These results suggest that HRV decreases during aging. ET seems to attenuate this process, promoting a reduction in sympathetic activity on the heart and contributing to the cardioprotective effect of estrogen hormones.

Saved in:
Bibliographic Details
Main Authors: Neves,V.F.C., Silva de Sá,M.F., Gallo Jr.,L., Catai,A.M., Martins,L.E.B., Crescêncio,J.C., Perpétuo,N.M., Silva,E.
Format: Digital revista
Language:English
Published: Associação Brasileira de Divulgação Científica 2007
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2007000400007
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0100-879X2007000400007
record_format ojs
spelling oai:scielo:S0100-879X20070004000072008-02-12Autonomic modulation of heart rate of young and postmenopausal women undergoing estrogen therapyNeves,V.F.C.Silva de Sá,M.F.Gallo Jr.,L.Catai,A.M.Martins,L.E.B.Crescêncio,J.C.Perpétuo,N.M.Silva,E. Heart rate variability Aging Menopause Estrogen therapy The aim of the present study was to determine whether estrogen therapy (ET) reduces alterations of the autonomic control of heart rate (HR) due to hypoestrogenism and aging. Thirteen young (24 ± 2.6 years), 10 postmenopausal (53 ± 4.6 years) undergoing ET (PM-ET), and 14 postmenopausal (56 ± 2.6 years) women not undergoing ET (PM) were studied. ET consisted of 0.625 mg/day conjugated equine estrogen. HR was recorded continuously for 8 min at rest in the supine and sitting positions. HR variability (HRV) was analyzed by time (SDNN and rMSSD indices) and frequency domain methods. Power spectral components are reported as normalized units (nu) at low (LF) and high (HF) frequencies, and as LF/HF ratio. Intergroup comparisons: SDNN index was higher in young (median: supine, 47 ms; sitting, 42 ms) than in PM-ET (33; 29 ms) and PM (31; 29 ms) women (P < 0.05). PM showed lower HFnu, higher LFnu and higher LF/HF ratio (supine: 44, 56, 1.29; sitting: 38, 62, 1.60) than the young group in the supine position (61, 39, 0.63) and the PM-ET group in the sitting position (57, 43, 0.75; P < 0.05). Intragroup comparisons: HR was lower in the supine than in the sitting position for all groups (P < 0.05). The HRV decrease from the supine to the sitting position was significant only in the young group. These results suggest that HRV decreases during aging. ET seems to attenuate this process, promoting a reduction in sympathetic activity on the heart and contributing to the cardioprotective effect of estrogen hormones.info:eu-repo/semantics/openAccessAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research v.40 n.4 20072007-04-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2007000400007en10.1590/S0100-879X2006005000080
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Neves,V.F.C.
Silva de Sá,M.F.
Gallo Jr.,L.
Catai,A.M.
Martins,L.E.B.
Crescêncio,J.C.
Perpétuo,N.M.
Silva,E.
spellingShingle Neves,V.F.C.
Silva de Sá,M.F.
Gallo Jr.,L.
Catai,A.M.
Martins,L.E.B.
Crescêncio,J.C.
Perpétuo,N.M.
Silva,E.
Autonomic modulation of heart rate of young and postmenopausal women undergoing estrogen therapy
author_facet Neves,V.F.C.
Silva de Sá,M.F.
Gallo Jr.,L.
Catai,A.M.
Martins,L.E.B.
Crescêncio,J.C.
Perpétuo,N.M.
Silva,E.
author_sort Neves,V.F.C.
title Autonomic modulation of heart rate of young and postmenopausal women undergoing estrogen therapy
title_short Autonomic modulation of heart rate of young and postmenopausal women undergoing estrogen therapy
title_full Autonomic modulation of heart rate of young and postmenopausal women undergoing estrogen therapy
title_fullStr Autonomic modulation of heart rate of young and postmenopausal women undergoing estrogen therapy
title_full_unstemmed Autonomic modulation of heart rate of young and postmenopausal women undergoing estrogen therapy
title_sort autonomic modulation of heart rate of young and postmenopausal women undergoing estrogen therapy
description The aim of the present study was to determine whether estrogen therapy (ET) reduces alterations of the autonomic control of heart rate (HR) due to hypoestrogenism and aging. Thirteen young (24 ± 2.6 years), 10 postmenopausal (53 ± 4.6 years) undergoing ET (PM-ET), and 14 postmenopausal (56 ± 2.6 years) women not undergoing ET (PM) were studied. ET consisted of 0.625 mg/day conjugated equine estrogen. HR was recorded continuously for 8 min at rest in the supine and sitting positions. HR variability (HRV) was analyzed by time (SDNN and rMSSD indices) and frequency domain methods. Power spectral components are reported as normalized units (nu) at low (LF) and high (HF) frequencies, and as LF/HF ratio. Intergroup comparisons: SDNN index was higher in young (median: supine, 47 ms; sitting, 42 ms) than in PM-ET (33; 29 ms) and PM (31; 29 ms) women (P < 0.05). PM showed lower HFnu, higher LFnu and higher LF/HF ratio (supine: 44, 56, 1.29; sitting: 38, 62, 1.60) than the young group in the supine position (61, 39, 0.63) and the PM-ET group in the sitting position (57, 43, 0.75; P < 0.05). Intragroup comparisons: HR was lower in the supine than in the sitting position for all groups (P < 0.05). The HRV decrease from the supine to the sitting position was significant only in the young group. These results suggest that HRV decreases during aging. ET seems to attenuate this process, promoting a reduction in sympathetic activity on the heart and contributing to the cardioprotective effect of estrogen hormones.
publisher Associação Brasileira de Divulgação Científica
publishDate 2007
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2007000400007
work_keys_str_mv AT nevesvfc autonomicmodulationofheartrateofyoungandpostmenopausalwomenundergoingestrogentherapy
AT silvadesamf autonomicmodulationofheartrateofyoungandpostmenopausalwomenundergoingestrogentherapy
AT gallojrl autonomicmodulationofheartrateofyoungandpostmenopausalwomenundergoingestrogentherapy
AT cataiam autonomicmodulationofheartrateofyoungandpostmenopausalwomenundergoingestrogentherapy
AT martinsleb autonomicmodulationofheartrateofyoungandpostmenopausalwomenundergoingestrogentherapy
AT crescenciojc autonomicmodulationofheartrateofyoungandpostmenopausalwomenundergoingestrogentherapy
AT perpetuonm autonomicmodulationofheartrateofyoungandpostmenopausalwomenundergoingestrogentherapy
AT silvae autonomicmodulationofheartrateofyoungandpostmenopausalwomenundergoingestrogentherapy
_version_ 1756391189595029504